Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

IMMUNE1 LAB MIDTERM AND FINALS > EXPERIMENT 15-16 POST LAB: SUMMARY OF THE E HEPATITIS VIRUSES AND THEIR ASSOCIATED SEROLOGICAL AND MOLECULAR MARKERS > Flashcards

EXPERIMENT 15-16 POST LAB: SUMMARY OF THE E HEPATITIS VIRUSES AND THEIR ASSOCIATED SEROLOGICAL AND MOLECULAR MARKERS Flashcards

1
Q

RNA Picornaviridae

A

HAV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Fecal, oral

A

HAV
HEV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Progression to Chronic State: No

A

HAV
HEV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Progression to Chronic State: Yes

A

HBV
HCV
HDV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

DNA Hepadnaviridae

A

HBV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Parental, sexual, perinatal

A

HBV
HCV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

RNA Flaviviridae

A

HCV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

RNA Genus Deltavirus

A

HDV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

RNA Hepeviridae

A

HEV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Low risk of fulminant liver disease

A

HAV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

10 to 90 percent of cases may develop chronic hepatitis (depending on age), with increased risk for liver cirrhosis and hepatocellular carcinoma

A

HBV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Eighty-five percent develop chronic infection, with increased risk of cirrhosis, hepatocellular carcinoma, or autoimmune manifestation

A

HCV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Increased risk of developing fulminant hepatitis, cirrhosis, or hepatocellular carcinoma

A

HDV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Fulminant liver failure in pregnant women

A

HEV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Acute hepatitis A

A

IgM anti-HAV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Immunity to hepatitis A

A

Total anti-HAV

17
Q

Detection of HAV in clinical, food, or water samples

A

HAV RNA

18
Q

Active hepatitis B infection
Active hepatitis B with high degree of infectivity

A

HBsAg

19
Q

Current or recent acute hepatitis B

A

IgM anti-HBc

20
Q

Current or recent acute hepatitis B

A

Total anti-HBc

21
Q

Recovery from hepatitis B

A

anti-HBe

22
Q

Immunity to hepatitis B

A

anti-HBs

23
Q

Current or past hepatitis C infection

A

Anti-HCV

24
Q

Current hepatitis C infection

A

HCV RNA

25
Q

viral may be used to monitor effectiveness of therapy

A

HCV RNA

26
Q

also used to determine HCV genotype

A

HCV RNA

27
Q

Acute or chronic hepatitis D

A

IgM-anti-HDV

28
Q

Recovery from hepatitis D or chronic hepatitis D

A

IgG-anti-HDV

29
Q

Active HDV infection; viral load may be used to monitor effectiveness of therapy

A

HDV RNA

30
Q

Current hepatitis E infection

A

IgM anti-HEV

31
Q

Current of part hepatitis E infection

A

IgG anti-HEV

32
Q

Current hepatitis E infection

A

HEV RNA

33
Q

Acute, atypical, or occult hepatitis B; viral load may be used to monitor effectiveness of therapy

A

anti-HBs

IMMUNE1 LAB MIDTERM AND FINALS (16 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions